Rare chance
The difficulties of identifying and treating rare diseases
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
Flagged up
How pharma can utilise the power of Nordic real-world data
Turning point
From data to action – the healthcare revolution is gaining momentum
Old moves
The age-old challenge of diversity in clinical studies
Time after time
Overcoming time perception challenges in dementia through technology
Primary goals
How can pharma re-engage with primary care?
Vaccine visionaries
Pierre Morgon is Executive Vice President of Portfolio Strategy and Supranational Affairs, as well as Managing Director Europe, at CanSino Biologics
Dr Know
The ‘Clinician of the Future 2023’ report suggests that healthcare professionals are preparing to embrace generative AI
